Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of MultiHance in Pediatric Patients

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Between 2 and 17 years of age~* Informed consent from parents~* Assent from patient where required~* Known or highly suspected disease of the CNS and referred for either cranial or spinal MRI examination~Exclusion Criteria:~* Contraindication to MRI~* Undergoing MRI in an emergency situation~* Known allergy to one or more of the ingredients in MultiHance~* Sickle cell anemia moderate to severe renal impairment~* Received another investigational compound within 30 days~* Pregnancy~* Lactating females~* Likely to undergo an invasive procedure within 72 hours of receiving MultiHance

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Gadobenate Dimeglumine (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).